Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved the first-ever mRNA-1345 vaccine (mRESVIA ...
Gene therapy is a new medical breakthrough which has, in reality, been several decades in the making. The concept was first suggested 50 years ago as a possibility for targeted treatments, but it ...
Welcome to 2024's regulatory tracker for Fierce Pharma. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications.
An advisory committee for the Food and Drug Administration (FDA) voted against recommending MDMA-assisted therapy for PTSD, drawing backlash from lawmakers and advocates. The members of the FDA ...
Five children who were born completely deaf have had some reversal of hearing loss after receiving a "groundbreaking" gene therapy. The clinical trial, which was co-led by Mass Eye and Ear in ...
At Tuesday’s meeting, Lykos Therapeutics presented positive data from two late-stage clinical trials that used MDMA in combination with therapy to treat PTSD. Many of the FDA advisory committee ...
NEW YORK, May 31 (UPI) --Researchers are engineering ways to alter genes or swap flawed ones with healthy replacements, hoping to cure diseases or enable the body to better combat them. These ...
The centrally acting alpha2-adrenergic agonist is approved for patients 6 years of age and older. HealthDay News — The US Food and Drug Administration has approved once-daily Onyda XR (clonidine ...
It is the first FDA approval of targeted therapy for pediatric patients under 12 years of age with RET alterations. Read Next: Eli Lilly Makes Largest Manufacturing Investment In Its History To ...
This is the first FDA approval of targeted therapy for pediatric patients <12 years of age with RET alterations. Selpercatinib was previously granted accelerated approval for thyroid cancer ...